Truven Health Analytics Announces Expected Timing of Notes Exchange Offer
Truven Health Analytics Inc. (the “Company”), formerly the Healthcare business of Thomson Reuters, announced today that it has postponed until May 2013 the commencement of its planned A/B notes exchange offer in respect of its 10.625% Senior Notes due 2020 (the “Notes”) that were issued in a Rule 144A transaction on June 6, 2012 in connection with the acquisition of the Company by private equity firm Veritas Capital. The Company is required to conduct the exchange offer of SEC registered notes for the Notes pursuant to a registration rights agreement entered into at the time that the Notes were issued. The Company expects to commence the exchange offer in early May 2013, subject to completion of the SEC review and comment process. The Company has delayed commencement of the exchange offer to enable it to focus its efforts on completing the transition to a standalone entity and to facilitate preparation of financial statements for the registration statement based on its fiscal year end December 31, 2012. Pursuant to the terms of the registration rights agreement, additional interest of 0.25% will accrue on the Notes commencing March 4, 2013 until and including the date the exchange offer is completed, assuming the exchange offer closes within the time frame currently anticipated.
This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any securities.
For Truven Health Analytics Inc.
John Roderick, 631-584-2200